期刊文献+

PCNA、VEGF、ER在甲状腺乳头状癌中的表达及临床意义 被引量:5

下载PDF
导出
摘要 目的探讨增殖细胞核抗原(PCNA)、血管内皮生长因子(VEGF)、雌激素受体(ER)在甲状腺乳头状癌等组织中的表达及临床意义。方法采用免疫组织化学技术S-P法检测58例甲状腺乳头状癌、30例甲状腺滤泡状腺瘤和30例癌旁正常甲状腺组织的PCNA、VEGF、ER表达。结果 PCNA、VEGF、ER在甲状腺乳头状癌中的表达率显著高于甲状腺滤泡状腺瘤组织及癌旁正常甲状腺组织(P<0.01);PCNA与VEGF呈正相关关系(r=0.8,P<0.01),与ER呈负相关关系(r=-0.3,P<0.05)。结论 PCNA、VEGF、ER表达可作为甲状腺乳头状癌的协助诊断指标,对临床治疗和预后判断具有重要的指导意义。
出处 《山东医药》 CAS 北大核心 2010年第33期77-78,共2页 Shandong Medical Journal
基金 河北省卫生厅立项课题(06097)
  • 相关文献

参考文献8

  • 1Cvejic D, Savin S, Petrovic I, et al. Galectin-3 and proliferating cell nuclear antigen (PCNA) expressed in papillary thyroid carcinoma[J]. Exp Oncol, 2005,27(3) :210-214.
  • 2Augustynowicz A, Dzieciol J, Barwijuk-Machala M, et al. Assessment of proliferative activity of thyroid hurthle cell tumors using PC- NA, Ki-67 and AgNOR methods[J]. Folia, 2004,42(3):165- 169.
  • 3Tateyama H, Yang YP, EimoLo T, et al. Proliferative cell nnclear antigen expression in follicular tumors of the thyroid with special reference to osyphilic cell lesions[ J]. Virchows Arch, 1994,424 (5) :533-537.
  • 4Leung DW, Cachianes G, Kuang WT, et al. Vascular endothelial growth factor is a secreted angiognic mitogen [ J ]. Science, 1989, 246(4935) :1306-1309.
  • 5Turtle RM, Fleisher M, Francis GL, et al. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyreid cancer but not increased by short term TSH stimulation [ J ]. CIin Endocrinal Metab, 2002,87 (4) : 1737-1738.
  • 6Palyi L, Peter I, Paubner D, et al. Establishment characterizatism and drug sensity of a neanaplastic thyroid carcinoma cell line [ J ]. Arch Cell Pathol, 1993,63(4) :2634265.
  • 7Van Hoeven K, Botet M. Estrogen and progesterone receptor content was in human thyroid disease[J]. Am J Clin Pathol, 1993,99(2) : 175-185.
  • 8Lee ML, Chen GC, Vlantis AC, et al. Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of BcI-XI[ J]. Cancer J, 2005,11 (2) :104-105.

同被引文献47

  • 1胡元晶,曲芃芃.VEGF及其受体在上皮性卵巢癌中的表达及与血管生成的关系[J].中国肿瘤临床,2006,33(23):1346-1349. 被引量:10
  • 2刘存根.亚急性甲状腺炎临床特点及诊治体会[J].临床误诊误治,2007,20(4):56-57. 被引量:5
  • 3Duininck T M,van Heerden J A,Fatourechi V,et al.de Quervain's thyroiditis:surgical experience[J].Endocr Pract,2002,8(4):255-258.
  • 4Ferraresi V, Nuzzo C, Zoccali C,et al. Chordoma : clinical characteris- tics,management and prognosis of a case series of 25 patients [ J ]. BMC Cancer,2010,10:22.
  • 5Tong AW, Stone MJ. Prospects for CIM0 - directed experimental therapy of human cancer [J]. Cancer Gene Ther,2003 ,1:1 - 13.
  • 6Yang HL,Zhu LF,Ebraheim NA,et al. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization [ J ]. Spine,2009,12 : 972 - 980.
  • 7Sumpio BE ,Yun S,Cordova AC ,et al. MAP kinases (ERK1/2 ,p38) and AKT can be phosphorylated by shear stress independently of PE- CAM - 1 ( CD31 ) in vascular endothelial cells [ J]. J Biology Chem- istry,2005,12:11185 - 11191.
  • 8廖二元 超楚生.内分泌学[M].北京:人民卫生出版社,2001.610-611.
  • 9高炳玉,张鹏,夏立平.亚急性甲状腺炎误诊为甲状腺癌17例分析[J].中国肿瘤,2007,16(10):844-845. 被引量:6
  • 10McNeil C. Annual cancer statistics report raises key ques- tions[J]. J Natl Cancer Inst, 2006,98(22) :1598-1599.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部